A former prostate cancer patient who got the all-clear said taking part in a trial that cut his radiotherapy treatments ...

A Rugby hospital charity trustee said a new radiotherapy treatment that could help prostate cancer patients has been ...

Recent years have seen remarkable progress in the application of radiotherapy for the management of genitourinary (GU) malignancies, including prostate, ...

The Cancer Center at University of Maryland Shore Regional Health (UM SRH) announces the appointment of Ashraf Youssef, MD as ...

Prostate cancer is highly treatable when detected early, as it carries a favourable prognosis. Therefore, awareness among ...

For patients with oligometastatic cancers, particularly kidney or prostate, stereotactic body radiotherapy may frequently ...

A phase 2 trial supports SBRT for primary treatment of localized RCC. Stereotactic body radiotherapy (SBRT) showed favorable long-term local control and cause-specific survival (CSS) in a phase 2 ...

Stereotactic body radiotherapy (SBRT) showed good local control and survival for limited metastatic/progressive cancers. Two-thirds of patients were alive at 2 years with minimal serious toxicity ...

Precision-targeted radiation is proving a match for surgery in early-stage lung cancer, offering patients similar long-term survival with less invasiveness, and potentially transforming how this ...

The phase 3 NRG GU-005 trial did not show a DFS benefit for SBRT vs IMRT in intermediate-risk prostate cancer, but SBRT decreased rectal toxicity. Stereotactic body radiation therapy (SBRT) preserves ...

Rediscovering radiation medicine Radiation oncologist Catheryn Yashar from UC San Diego Health introduces the ASTRO news briefing. (Courtesy: ©ASTRO/Todd Buchanan 2025) “ASTRO 2025 has opened with a ...

Regarding disease-free survival, 88.6% of patients in the SBRT group were free from disease progression after three years, compared to 92.1% receiving longer courses of radiation. The difference was ...